Literature DB >> 23103677

Long-term survival after allogeneic-matched sibling PBSC transplantation with conditioning consisting of low-dose busilvex and fludarabine in a 3-year-old boy with ataxia-telangiectasia syndrome and ALL.

M Ussowicz, J Musiał, E Duszeńko, O Haus, K Kałwak.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23103677     DOI: 10.1038/bmt.2012.207

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  10 in total

1.  Nijmegen Breakage Syndrome: Clinical and Immunological Features, Long-Term Outcome and Treatment Options - a Retrospective Analysis.

Authors:  Beata Wolska-Kuśnierz; Hanna Gregorek; Krystyna Chrzanowska; Barbara Piątosa; Barbara Pietrucha; Edyta Heropolitańska-Pliszka; Małgorzata Pac; Maja Klaudel-Dreszler; Larysa Kostyuchenko; Srdjan Pasic; Laszlo Marodi; Bernd H Belohradsky; Peter Čižnár; Anna Shcherbina; Sara Sebnem Kilic; Ulrich Baumann; Markus G Seidel; Andrew R Gennery; Małgorzata Syczewska; Bożena Mikołuć; Krzysztof Kałwak; Jan Styczyński; Anna Pieczonka; Katarzyna Drabko; Anna Wakulińska; Benjamin Gathmann; Michael H Albert; Urszula Skarżyńska; Ewa Bernatowska
Journal:  J Clin Immunol       Date:  2015-08-14       Impact factor: 8.317

2.  Low-dose irradiation prior to bone marrow transplantation results in ATM activation and increased lethality in Atm-deficient mice.

Authors:  J Pietzner; B M Merscher; P C Baer; R P Duecker; O Eickmeier; D Fußbroich; P Bader; D Del Turco; R Henschler; S Zielen; R Schubert
Journal:  Bone Marrow Transplant       Date:  2016-01-11       Impact factor: 5.483

3.  Allogeneic-matched sibling stem cell transplantation in a 13-year-old boy with ataxia telangiectasia and EBV-positive non-Hodgkin lymphoma.

Authors:  R Beier; K-W Sykora; W Woessmann; B Maecker-Kolhoff; M Sauer; H H Kreipe; T Dörk-Bousset; C Kratz; M Lauten
Journal:  Bone Marrow Transplant       Date:  2016-05-09       Impact factor: 5.483

4.  Radiation-sensitive severe combined immunodeficiency: The arguments for and against conditioning before hematopoietic cell transplantation--what to do?

Authors:  Morton J Cowan; Andrew R Gennery
Journal:  J Allergy Clin Immunol       Date:  2015-06-06       Impact factor: 10.793

5.  Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders.

Authors:  James Slack; Michael H Albert; Dmitry Balashov; Bernd H Belohradsky; Alice Bertaina; Jack Bleesing; Claire Booth; Jochen Buechner; Rebecca H Buckley; Marie Ouachée-Chardin; Elena Deripapa; Katarzyna Drabko; Mary Eapen; Tobias Feuchtinger; Andrea Finocchi; H Bobby Gaspar; Sujal Ghosh; Alfred Gillio; Luis I Gonzalez-Granado; Eyal Grunebaum; Tayfun Güngör; Carsten Heilmann; Merja Helminen; Kohei Higuchi; Kohsuke Imai; Krzysztof Kalwak; Nubuo Kanazawa; Gülsün Karasu; Zeynep Y Kucuk; Alexandra Laberko; Andrzej Lange; Nizar Mahlaoui; Roland Meisel; D Moshous; Hideki Muramatsu; Suhag Parikh; Srdjan Pasic; Irene Schmid; Catharina Schuetz; Ansgar Schulz; Kirk R Schultz; Peter J Shaw; Mary A Slatter; Karl-Walter Sykora; Shinobu Tamura; Mervi Taskinen; Angela Wawer; Beata Wolska-Kuśnierz; Morton J Cowan; Alain Fischer; Andrew R Gennery
Journal:  J Allergy Clin Immunol       Date:  2017-04-07       Impact factor: 10.793

Review 6.  Ataxia telangiectasia: a review.

Authors:  Cynthia Rothblum-Oviatt; Jennifer Wright; Maureen A Lefton-Greif; Sharon A McGrath-Morrow; Thomas O Crawford; Howard M Lederman
Journal:  Orphanet J Rare Dis       Date:  2016-11-25       Impact factor: 4.123

Review 7.  Pre-emptive Allogeneic Hematopoietic Stem Cell Transplantation in Ataxia Telangiectasia.

Authors:  Shahrzad Bakhtiar; Sandra Woelke; Sabine Huenecke; Matthias Kieslich; Alexander Malcolm Taylor; Ralf Schubert; Stefan Zielen; Peter Bader
Journal:  Front Immunol       Date:  2018-10-29       Impact factor: 7.561

8.  Reconstitution of the Ataxia-Telangiectasia Cellular Phenotype With Lentiviral Vectors.

Authors:  Diana Carranza; Sara Torres-Rusillo; Gloria Ceballos-Pérez; Eva Blanco-Jimenez; Martin Muñoz-López; José L García-Pérez; Ignacio J Molina
Journal:  Front Immunol       Date:  2018-11-20       Impact factor: 7.561

9.  The natural history of ataxia-telangiectasia (A-T): A systematic review.

Authors:  Emily Petley; Alexander Yule; Shaun Alexander; Shalini Ojha; William P Whitehouse
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.752

10.  Atm reactivation reverses ataxia telangiectasia phenotypes in vivo.

Authors:  Sara Di Siena; Federica Campolo; Roberto Gimmelli; Chiara Di Pietro; Daniela Marazziti; Susanna Dolci; Andrea Lenzi; Andre Nussenzweig; Manuela Pellegrini
Journal:  Cell Death Dis       Date:  2018-02-22       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.